OSI Board Rejects Astellas $3.5B Bid
The board of OSI Pharmaceuticals Inc. has rejected a $3.5 billion hostile takeover bid from a unit of Japanese pharmaceutical giant Astellas Pharma Inc., instead putting out feelers for other suitors....To view the full article, register now.
Already a subscriber? Click here to view full article